S Oravec

Summary

Publications

  1. ncbi Hyper-betalipoproteinemia LDL 1,2: a newly identified nonatherogenic hypercholesterolemia in a group of hypercholesterolemic subjects
    Stanislav Oravec
    2nd Department of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
    Neuro Endocrinol Lett 32:322-7. 2011
  2. pmc Effect of a plant sterol, fish oil and B vitamin combination on cardiovascular risk factors in hypercholesterolemic children and adolescents: a pilot study
    Iveta Garaiova
    Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, 813 72, Slovakia
    Nutr J 12:7. 2013
  3. ncbi Lipoprotein Lp(a) in lipoprotein spectrum indentified by Lipoprint LDL system
    Stanislav Oravec
    2nd Department of Internal Medicine, Faculty of Medicine, Comenius University, 813 69 Bratislava, Slovakia
    Neuro Endocrinol Lett 34:309-13. 2013
  4. ncbi [Changes in lipoprotein spectrum in patients with the diagnosis of extremity vascular ischemic disease]
    S Oravec
    II interná klinika Lekárskej fakulty UK Bratislava, Slovenska republika
    Vnitr Lek 56:620-3. 2010
  5. ncbi [Serum lipoprotein profile in newly recognized arterial hypertension. The role of atherogenic lipoproteins in the pathogenesis of disease]
    S Oravec
    II interná klinika Lekárskej fakulty UK a FNsP Bratislava, Slovenska republika
    Vnitr Lek 56:967-71. 2010
  6. ncbi Contribution of the atherogenic lipoprotein profile to the development of arterial hypertension
    S Oravec
    2nd Departmenpt of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
    Bratisl Lek Listy 112:4-7. 2011
  7. ncbi Atherogenic normolipidemia - a new phenomenon in the lipoprotein profile of clinically healthy subjects
    Stanislav Oravec
    2nd Department of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
    Neuro Endocrinol Lett 32:317-21. 2011
  8. ncbi Lipoprotein profile in patients who survive a stroke
    Stanislav Oravec
    2nd Department of Internal Medicine, Comenius University, Bratislava, Slovakia
    Neuro Endocrinol Lett 32:496-501. 2011
  9. ncbi HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia
    Stanislav Oravec
    2nd Department of Internal Medicine, Comenius University, Bratislava, Slovakia
    Neuro Endocrinol Lett 32:502-9. 2011

Collaborators

Detail Information

Publications9

  1. ncbi Hyper-betalipoproteinemia LDL 1,2: a newly identified nonatherogenic hypercholesterolemia in a group of hypercholesterolemic subjects
    Stanislav Oravec
    2nd Department of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
    Neuro Endocrinol Lett 32:322-7. 2011
    ..The older subjects with hyper-betalipoproteinemia and a non-atherogenic lipoprotein profile had only mild signs of clinically irrelevant aortic valve sclerosis...
  2. pmc Effect of a plant sterol, fish oil and B vitamin combination on cardiovascular risk factors in hypercholesterolemic children and adolescents: a pilot study
    Iveta Garaiova
    Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, 813 72, Slovakia
    Nutr J 12:7. 2013
    ....
  3. ncbi Lipoprotein Lp(a) in lipoprotein spectrum indentified by Lipoprint LDL system
    Stanislav Oravec
    2nd Department of Internal Medicine, Faculty of Medicine, Comenius University, 813 69 Bratislava, Slovakia
    Neuro Endocrinol Lett 34:309-13. 2013
    ..The persons with increased levels of lipoprotein(a) and contemporarily increased cholesterol level in serum, are at increased risk of the inception of cardiovascular or cerebrovascular event even 3-times...
  4. ncbi [Changes in lipoprotein spectrum in patients with the diagnosis of extremity vascular ischemic disease]
    S Oravec
    II interná klinika Lekárskej fakulty UK Bratislava, Slovenska republika
    Vnitr Lek 56:620-3. 2010
    ..These persons represent a risk population. Till now, the facilities for identifying of these "normolipemic persons at risk" are limited...
  5. ncbi [Serum lipoprotein profile in newly recognized arterial hypertension. The role of atherogenic lipoproteins in the pathogenesis of disease]
    S Oravec
    II interná klinika Lekárskej fakulty UK a FNsP Bratislava, Slovenska republika
    Vnitr Lek 56:967-71. 2010
    ....
  6. ncbi Contribution of the atherogenic lipoprotein profile to the development of arterial hypertension
    S Oravec
    2nd Departmenpt of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
    Bratisl Lek Listy 112:4-7. 2011
    ..Impaired lipoprotein metabolism results in overproduction of triglyceride-rich particles and LDL 3-7 subfractions - small dense LDL - a strongly atherogenic LDL subpopulation accelerating the development of arterial hypertension...
  7. ncbi Atherogenic normolipidemia - a new phenomenon in the lipoprotein profile of clinically healthy subjects
    Stanislav Oravec
    2nd Department of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
    Neuro Endocrinol Lett 32:317-21. 2011
    ..Individuals with atherogenic normolipidemia are at increased risk to develop premature atherothrombosis and experience a sudden cardiovascular event...
  8. ncbi Lipoprotein profile in patients who survive a stroke
    Stanislav Oravec
    2nd Department of Internal Medicine, Comenius University, Bratislava, Slovakia
    Neuro Endocrinol Lett 32:496-501. 2011
    ..Conversely, decreased serum concentration of LDL1 suggests, that the LDL1 subfraction does not contribute to the creation of an atherogenic lipoprotein profile of specific individuals, i.e., those who survived a stroke...
  9. ncbi HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia
    Stanislav Oravec
    2nd Department of Internal Medicine, Comenius University, Bratislava, Slovakia
    Neuro Endocrinol Lett 32:502-9. 2011
    ....